Author
Listed:
- Olivier Pernet
(and Los Angeles General Medical Center)
- Toinette Frederick
(and Los Angeles General Medical Center)
- Amila Adili
(University of Southern California)
- Jay Hudgins
(and Los Angeles General Medical Center)
- Patricia Anthony
(and Los Angeles General Medical Center)
- Gwyndolyn McCaney
(and Los Angeles General Medical Center)
- Wendy J. Mack
(University of Southern California
Keck School of Medicine of USC)
- Eunice Noriega
(and Los Angeles General Medical Center)
- Jennifer Lopez
(and Los Angeles General Medical Center)
- Steven Balog
(and Los Angeles General Medical Center)
- Manoj Biniwale
(and Los Angeles General Medical Center)
- Amy Yeh
(and Los Angeles General Medical Center)
- Allison Bearden
(and Los Angeles General Medical Center)
- Rangasamy Ramanathan
(and Los Angeles General Medical Center)
- Andrea Kovacs
(and Los Angeles General Medical Center
and Los Angeles General Medical Center
Keck School of Medicine of USC)
Abstract
It is estimated that in utero SARS-CoV-2 infection is rare. However, few studies have systematically assessed for IgA and IgM antibodies indicating potential in utero response to SARS-CoV-2 infection using multi-isotype serology, and no studies have assessed in utero infection markers in relation to circulating variants. Between October 21, 2021 and February 15, 2023, remnant cord blood samples (CBS) from neonates born at a single hospital in Los Angeles, were systematically tested for serological markers suggesting in utero infection. SARS-CoV-2 specific fetal IgA and/or IgM antibodies were detected in 28.7% (298/1038 CBS, 95% CI: 26.0, 31.6), higher than previous in utero infection estimates that used only PCR and/or IgM. Importantly, the probability of detecting markers of in utero infection varied by month (P-value = 0.0144). The prevalence of fetal IgA/IgM varied with the emergence of new variants, increasing during the BA.1 wave with a peak in February 2022 at 36% (18/50, 95% CI: 22.7-49.3) and again during the BA.4/5 wave, with a peak at 48.8% in September 2022 (39/80, 95% CI 37.8-59.7), suggesting variant-related fluctuations. These data suggest it may be useful to identify SARS-Cov-2 in utero exposure at birth so these newborns may be more closely followed for adverse clinical outcomes.
Suggested Citation
Olivier Pernet & Toinette Frederick & Amila Adili & Jay Hudgins & Patricia Anthony & Gwyndolyn McCaney & Wendy J. Mack & Eunice Noriega & Jennifer Lopez & Steven Balog & Manoj Biniwale & Amy Yeh & All, 2025.
"Cord blood IgA/M reveals in utero response to SARS-CoV-2 with fluctuations in relation to circulating variants,"
Nature Communications, Nature, vol. 16(1), pages 1-8, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-58768-5
DOI: 10.1038/s41467-025-58768-5
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-58768-5. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.